<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03930589</url>
  </required_header>
  <id_info>
    <org_study_id>V1 November 15, 2013</org_study_id>
    <nct_id>NCT03930589</nct_id>
  </id_info>
  <brief_title>Remote Ischemic Conditioning in STEMI to Decrease Infarct Size</brief_title>
  <acronym>RemCon-STEMI</acronym>
  <official_title>A Multi-center Randomized Trial of Remote Ischemic Conditioning to Reduce Infarct Size in Patients With an ST-Elevation Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alberta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian VIGOUR Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Alberta</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Following acute STEMI patients may have significant myocardial damage and subsequent heart
      failure. There is currently conflicting data regarding the benefit of remote ischemic
      conditioning to decrease the magnitude of infarction. Remote ischemic condition is a process
      where by repetitive intermittent limb ischemia is used to decrease the magnitude of
      myocardial damage caused by coronary artery occlusion and the subsequent reperfusion injury
      in STEMI patients. RemCon-STEMI is a multicenter randomized trial to test the impact of
      remote ischemic conditioning in acute STEMI.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 8, 2013</start_date>
  <completion_date type="Actual">November 26, 2018</completion_date>
  <primary_completion_date type="Actual">August 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Remote ischemic condition versus standard of care</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Patient outcomes and markers blinded to randomization arm</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Composite of all cause death</measure>
    <time_frame>90 days</time_frame>
    <description>all cause death, cardiogenic shock or chf through 90 days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>long term survival</measure>
    <time_frame>up to 1 year</time_frame>
    <description>survival</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>myocardial infarction size</measure>
    <time_frame>within 72 hours of hospital admission</time_frame>
    <description>mi size using peak elevation of cardiac biomarkers</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ECG infarct size</measure>
    <time_frame>with 10 days or hospital discharge whichever occurs first</time_frame>
    <description>QRS score on baseline and discharge ECGS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reperfusion</measure>
    <time_frame>within 24 hours of admission to hospital</time_frame>
    <description>ST segment resolution 30 minutes post PCI</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">251</enrollment>
  <condition>STEMI</condition>
  <condition>CAD</condition>
  <arm_group>
    <arm_group_label>Standard of care</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>no intervention will occur in the standard of care arm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Remote Ischemic Conditioning</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Remote ischemic conditioning using BP cuff on left arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Remote Ischemic conditioning</intervention_name>
    <description>BP cuff inflation for 5 min and deflation for 5 mins with 4 cycles</description>
    <arm_group_label>Remote Ischemic Conditioning</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard of care</intervention_name>
    <description>Standard of care</description>
    <arm_group_label>Standard of care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients presenting with STEMI within 6 hours of symptom onset and:

          1. Are expected to receive reperfusion therapy with either fibrinolysis or primary PCI.

          2. Documented informed consent (verbal)

        Exclusion Criteria:

          1. Cardiogenic shock

          2. History of anatomical deformity or vascular complication that limit ability to conduct
             remote ischemic preconditioning
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 30, 2018</study_first_submitted>
  <study_first_submitted_qc>April 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 29, 2019</study_first_posted>
  <last_update_submitted>April 25, 2019</last_update_submitted>
  <last_update_submitted_qc>April 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alberta</investigator_affiliation>
    <investigator_full_name>Robert Welsh</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

